Overview:
The Ordinance No.660/2021 It would impose restrictions on exceptional and specific restrictions, measures and requirements for entry into the country, due to the risks of contamination and dissemination of the SARS-CoV-2 coronavirus (covid-19).
Introduction
Brazil’s National Health Surveillance Agency (Anvisa) Supervises and requires, by force of interministerial ordinance, that the traveler presents a negative PCR test for Covid-19 performed within 72 hours before the international flight (at the origin of the flight). The passenger in question arrived in Brazil with a negative test, asymptomatic.
However, after its arrival, Anvisa was informed at 9:12 pm on 11/27 about the positive result of a new RT-PCR test, performed by the laboratory located at Guarulhos airport.
In view of the result, the Agency notified the national, state, and municipal Strategic Information Center for Health Surveillance (CIEVS) at 1:07 am on 11/28. The Epidemiological Surveillance of the municipality of Guarulhos was also triggered to follow up the case.
After identification and testing positive for Covid-19, the patient was placed in isolation and is now under residential quarantine. The state and municipal health agencies and the Ministry of Health are following the case.
Anvisa Regulations for Travelers
As recommended by Anvisa, the Interministerial Ordinance No 660, of November 27, 2021, prohibited flights to Brazil from or through the Republic of South Africa, the Republic of Botswana, the Kingdom of Essuatíni, the Kingdom of Lesotho, the Republic of Namibia, and the Republic of Zimbabwe.
To read more about Ordinance No. 660/2021, click here (available only in Portuguese).
Alert for Brazilian Travelers:
According to the Ordinance in force, the Brazilian traveler coming from or passing through the Republic of South Africa, the Republic of Botswana, the Kingdom of Essuatini, the Kingdom of Lesotho, the Republic of Namibia and the Republic of Zimbabwe, in the last fourteen days before boarding, when entering the Brazilian territory, must remain in quarantine for fourteen days in the city of their destination.
Other Countries Subject to Travel Restrictions
Angola, Malawi, Mozambique, and Zambia
About Global Regulatory Partners
Global Regulatory Partners Inc, (GRP) is an American company that provides regulatory affairs, clinical, quality and safety services to medical devices, pharmaceutical, cosmetic and Food Supplement companies globally.
GRP headquarters is located in Massachusetts USA and its main affiliates are located in China, Japan, Brazil, and Mexico. GRP helps many life science companies register their products in different countries in compliance with local regulations.